OKYO Pharma Limited(OKYO)

Biotechnology · London, GL

$1.49+0.02 (+1.02%)

Delayed quote: Oct 6, 2026, 3:39 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T19:42:46.706Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:42:46.706Z.

Quote observation: 2026-10-06T19:39:30.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-03-31: N/A
Quote market capitalization: 56,975,102

FMP input reference: fae3dac89f6aae568c3e1e6131ec6a0b9ed594063ed7dd46d2bf25dadf8b5230

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OKYO Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

OKYO Competitors' Operating Cash Flow Yield

OKYO

OKYO Pharma Limited

Current

Market Cap

$56.98M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTB

Connect Biopharma Holdings Limited

vs OKYO

Market Cap

$57.33M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TLPH

Talphera, Inc.

vs OKYO

Market Cap

$57.61M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLD

Boundless Bio, Inc.

vs OKYO

Market Cap

$57.98M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INKT

MiNK Therapeutics, Inc.

vs OKYO

Market Cap

$58.54M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs OKYO

Market Cap

$58.72M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XLO

Xilio Therapeutics, Inc.

vs OKYO

Market Cap

$58.85M

Operating Cash Flow Yield

N/A

TTM Avg

39.02%

3Y Avg

39.02%

5Y Avg

39.02%

ACET

Adicet Bio, Inc.

vs OKYO

Market Cap

$58.43M

Operating Cash Flow Yield

N/A

TTM Avg

1.11%

3Y Avg

1.11%

5Y Avg

1.11%

ONCY

Oncolytics Biotech Inc.

vs OKYO

Market Cap

$60.04M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs OKYO

Market Cap

$51.79M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
OKYO Pharma Limited (OKYO)	$56.98M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$57.33M	N/A	N/A	N/A	N/A
Talphera, Inc. (TLPH)vs ›	$57.61M	N/A	N/A	N/A	N/A
Boundless Bio, Inc. (BOLD)vs ›	$57.98M	N/A	N/A	N/A	N/A
MiNK Therapeutics, Inc. (INKT)vs ›	$58.54M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$58.72M	N/A	N/A	N/A	N/A
Xilio Therapeutics, Inc. (XLO)vs ›	$58.85M	N/A	39.02%	39.02%	39.02%
Adicet Bio, Inc. (ACET)vs ›	$58.43M	N/A	1.11%	1.11%	1.11%
Oncolytics Biotech Inc. (ONCY)vs ›	$60.04M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.79M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

OKYO Operating Cash Flow Yield Metrics

OKYO Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics